Pharmaceutical Technology is using cookies

We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.

ContinueLearn More X
X
Analysis

Genetic studies: a powerful tool for testing combination therapies

A genetic study by MRC has suggested that combining lipoprotein lipase (LPL) enhancers with cholesterol lowering agents further reduces the risk of heart attacks than cholesterol lowering agents alone. This discovery could help pharma companies developing LPL enhancing drugs to design more successful trials.

Go Top